These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 26004783)

  • 1. Animal models for ebolavirus countermeasures discovery: what defines a useful model?
    Shurtleff AC; Bavari S
    Expert Opin Drug Discov; 2015 Jul; 10(7):685-702. PubMed ID: 26004783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonhuman primates as models for the discovery and development of ebolavirus therapeutics.
    Shurtleff AC; Warren TK; Bavari S
    Expert Opin Drug Discov; 2011 Mar; 6(3):233-50. PubMed ID: 22647202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Medical Countermeasures Against Ebolaviruses in Nonhuman Primate Models.
    Mire CE; Geisbert TW
    Methods Mol Biol; 2017; 1628():293-307. PubMed ID: 28573630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Ebola Virus Countermeasures in Guinea Pigs.
    Marzi A
    Methods Mol Biol; 2017; 1628():283-291. PubMed ID: 28573629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Syrian golden hamster model recapitulating ebola hemorrhagic fever.
    Ebihara H; Zivcec M; Gardner D; Falzarano D; LaCasse R; Rosenke R; Long D; Haddock E; Fischer E; Kawaoka Y; Feldmann H
    J Infect Dis; 2013 Jan; 207(2):306-18. PubMed ID: 23045629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ebola virus vaccines - reality or fiction?
    Mire CE; Geisbert TW; Feldmann H; Marzi A
    Expert Rev Vaccines; 2016 Nov; 15(11):1421-1430. PubMed ID: 27078187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ebola Virus: Pathogenesis and Countermeasure Development.
    Furuyama W; Marzi A
    Annu Rev Virol; 2019 Sep; 6(1):435-458. PubMed ID: 31567063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling the Disease Course of Zaire ebolavirus Infection in the Outbred Guinea Pig.
    Cross RW; Fenton KA; Geisbert JB; Mire CE; Geisbert TW
    J Infect Dis; 2015 Oct; 212 Suppl 2():S305-15. PubMed ID: 26038397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Considerations in the Use of Nonhuman Primate Models of Ebola Virus and Marburg Virus Infection.
    Geisbert TW; Strong JE; Feldmann H
    J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S91-7. PubMed ID: 26063223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ebola vaccine and treatment].
    Takada A
    Uirusu; 2015; 65(1):61-70. PubMed ID: 26923959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccines against 'the other' Ebolavirus species.
    Kozak RA; Kobinger GP
    Expert Rev Vaccines; 2016 Sep; 15(9):1093-100. PubMed ID: 27010528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in the development of vaccines for Ebola virus disease.
    Ohimain EI
    Virus Res; 2016 Jan; 211():174-85. PubMed ID: 26596227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathology of experimental aerosol Zaire ebolavirus infection in rhesus macaques.
    Twenhafel NA; Mattix ME; Johnson JC; Robinson CG; Pratt WD; Cashman KA; Wahl-Jensen V; Terry C; Olinger GG; Hensley LE; Honko AN
    Vet Pathol; 2013 May; 50(3):514-29. PubMed ID: 23262834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonhuman Primate Models of Ebola Virus Disease.
    Bennett RS; Huzella LM; Jahrling PB; Bollinger L; Olinger GG; Hensley LE
    Curr Top Microbiol Immunol; 2017; 411():171-193. PubMed ID: 28643203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal immunization with an adenovirus vaccine protects guinea pigs from Ebola virus transmission by infected animals.
    Wong G; Richardson JS; Cutts T; Qiu X; Kobinger GP
    Antiviral Res; 2015 Apr; 116():17-9. PubMed ID: 25596432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of Sudan Ebolavirus infection in ferrets.
    Kroeker A; He S; de La Vega MA; Wong G; Embury-Hyatt C; Qiu X
    Oncotarget; 2017 Jul; 8(28):46262-46272. PubMed ID: 28545034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing Antiviral Countermeasures Using Mouse Models of Ebolavirus Infection.
    Kroeker A; Griffin BD; Qiu X; Kobinger G
    Methods Mol Biol; 2017; 1628():273-282. PubMed ID: 28573628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and Characterization of a Guinea Pig-Adapted Sudan Virus.
    Wong G; He S; Wei H; Kroeker A; Audet J; Leung A; Cutts T; Graham J; Kobasa D; Embury-Hyatt C; Kobinger GP; Qiu X
    J Virol; 2016 Jan; 90(1):392-9. PubMed ID: 26491156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From bench to almost bedside: the long road to a licensed Ebola virus vaccine.
    Wong G; Mendoza EJ; Plummer FA; Gao GF; Kobinger GP; Qiu X
    Expert Opin Biol Ther; 2018 Feb; 18(2):159-173. PubMed ID: 29148858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aerosol exposure to Zaire ebolavirus in three nonhuman primate species: differences in disease course and clinical pathology.
    Reed DS; Lackemeyer MG; Garza NL; Sullivan LJ; Nichols DK
    Microbes Infect; 2011 Oct; 13(11):930-6. PubMed ID: 21651988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.